cancer vaccine

Biotech

Pfizer punts pair of orphan drugs amid rare disease R&D rethink

Pfizer dropped the drugs in a pipeline cull that also narrowed the opportunities open to the near-approval JAK3/TEC inhibitor ritlecitinib.
Nick Paul Taylor Jan 31, 2023 9:15am

Have mRNA cancer vaccines arrived? Biopharma execs weigh in

Jan 25, 2023 10:30am

Cancer vaccine-focused Elicio uses Angion as path to Nasdaq

Jan 17, 2023 8:45am

'We don't know' what the limits are for RNA therapies

Jan 9, 2023 6:00am

BioNTech's UK gov pact to get cancer therapies to 10K patients

Jan 6, 2023 12:29pm

Y-Mabs drops 3rd of staff, cancer vaccine ambitions

Jan 5, 2023 8:40am